Cargando…

FLT3(N676K) drives acute myeloid leukemia in a xenograft model of KMT2A-MLLT3 leukemogenesis

Detalles Bibliográficos
Autores principales:	Hyrenius-Wittsten, Axel, Pilheden, Mattias, Falqués-Costa, Antoni, Eriksson, Mia, Sturesson, Helena, Schneider, Pauline, Wander, Priscilla, Garcia-Ruiz, Cristian, Liu, Jian, Ågerstam, Helena, Hultquist, Anne, Lilljebjörn, Henrik, Stam, Ronald W., Järås, Marcus, Hagström-Andersson, Anna K.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2019
Materias:	Letter
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6756218/ https://www.ncbi.nlm.nih.gov/pubmed/30953031 http://dx.doi.org/10.1038/s41375-019-0465-1

Ejemplares similares

P479: TREATMENT IS SHAPING CLONAL EVOLUTION AND RESISTANCE PATTERNS IN MURINE KMT2A-REARRANGED LEUKEMIA WITH SUBCLONAL FLT3N676K
por: Falqués-Costa, Ton, et al.
Publicado: (2023)

De novo activating mutations drive clonal evolution and enhance clonal fitness in KMT2A-rearranged leukemia
por: Hyrenius-Wittsten, Axel, et al.
Publicado: (2018)

Duplex Sequencing Uncovers Recurrent Low-frequency Cancer-associated Mutations in Infant and Childhood KMT2A-rearranged Acute Leukemia
por: Pilheden, Mattias, et al.
Publicado: (2022)

KMT2A-MLLT3 AML Masquerading as JMML may Disguise Fatal Leukemia
por: Saad, Ashraf Abdullah, et al.
Publicado: (2019)

Dysregulated transcriptional networks in KMT2A- and MLLT10-rearranged T-ALL
por: Kang, Huining, et al.
Publicado: (2018)

Clinical and molecular response of acute myeloid leukemia harboring non-canonical FLT3 N676K driver mutations to contemporary FLT3 inhibitors
por: Roloff, Gregory W., et al.
Publicado: (2023)

The Partial Duplication of the 5′ Segment of KMT2A Revealed KMT2A-MLLT10 Rearrangement in a Boy with Acute Myeloid Leukemia
por: Fukushima, Hiroko, et al.
Publicado: (2017)

Mature B cell acute lymphoblastic leukaemia with KMT2A-MLLT3 transcripts in children: three case reports and literature reviews
por: Cui, Yinghui, et al.
Publicado: (2021)

IL1RAP is expressed in several subtypes of pediatric acute lymphoblastic leukemia and can be used as a target to eliminate ETV6::RUNX1-positive leukemia cells in preclinical models
por: Ågerstam, Helena, et al.
Publicado: (2022)

Dnmt3a deletion cooperates with the Flt3/ITD mutation to drive leukemogenesis in a murine model
por: Poitras, Jennifer L., et al.
Publicado: (2016)

The Myc/Max/Mxd Network Is a Target of Mutated Flt3 Signaling in Hematopoietic Stem Cells in Flt3-ITD-Induced Myeloproliferative Disease
por: Basit, Farhan, et al.
Publicado: (2018)

Discovery of an MLLT1/3 YEATS Domain Chemical Probe
por: Moustakim, Moses, et al.
Publicado: (2018)

Epigenetic changes in human model KMT2A leukemias highlight early events during leukemogenesis
por: Milan, Thomas, et al.
Publicado: (2020)

CD36 defines primitive chronic myeloid leukemia cells less responsive to imatinib but vulnerable to antibody-based therapeutic targeting
por: Landberg, Niklas, et al.
Publicado: (2018)

676 reactivos de terapéutica farmacológica
por: Gómez Portugal Salazar, Manuel
Publicado: (1987)

Umbilical cord blood transplantation can overcome the poor prognosis of KMT2A-MLLT3 acute myeloid leukemia and can lead to good GVHD-free/relapse-free survival
por: Tong, Juan, et al.
Publicado: (2021)

Editorial: Harnessing chemotherapy resistance and development of novel therapeutic strategies for acute leukemia with KMT2A (MLL)-gene rearrangements
por: Esposito, Maria Teresa, et al.
Publicado: (2022)

The complement receptor C3AR constitutes a novel therapeutic target in NPM1-mutated AML
por: von Palffy, Sofia, et al.
Publicado: (2022)

MuLV-related endogenous retroviral elements and Flt3 participate in aberrant end-joining events that promote B-cell leukemogenesis
por: Johnson, Radia M., et al.
Publicado: (2014)

Long Noncoding RNA SOCS2-AS Promotes Leukemogenesis in FLT3-ITD+ Acute Myeloid Leukemia Through miRNA-221
por: Zhang, Rong, et al.
Publicado: (2020)

Potent preclinical activity of FLT3-directed chimeric antigen receptor T-cell immunotherapy against FLT3-mutant acute myeloid leukemia and KMT2A-rearranged acute lymphoblastic leukemia
por: Niswander, Lisa M., et al.
Publicado: (2022)

Point Mutations in the FLT3-ITD Region Are Rare but Recurrent Alterations in Adult AML and Associated With Concomitant KMT2A-PTD
por: Stasik, Sebastian, et al.
Publicado: (2022)

Targeting GLUT1 in acute myeloid leukemia to overcome cytarabine resistance
por: Åbacka, Hannah, et al.
Publicado: (2021)

Modeling chronic myeloid leukemia in immunodeficient mice reveals expansion of aberrant mast cells and accumulation of pre-B cells
por: Askmyr, M, et al.
Publicado: (2014)

The process of leukemogenesis.
por: Irons, R D, et al.
Publicado: (1996)

Dissection of PIM serine/threonine kinases in FLT3-ITD–induced leukemogenesis reveals PIM1 as regulator of CXCL12–CXCR4-mediated homing and migration
por: Grundler, Rebekka, et al.
Publicado: (2009)

Further Activation of FLT3 Mutants by FLT3 Ligand
por: Zheng, Rui, et al.
Publicado: (2011)

Proton Losses and estimated Radioactivity Levels, Runs 667, 668 and 676
por: Tausch, L, et al.
Publicado: (1976)

The Elongation Complex Components BRD4 and MLLT3/AF9 Are Transcriptional Coactivators of Nuclear Retinoid Receptors
por: Flajollet, Sébastien, et al.
Publicado: (2013)

Involvement of AF1q/MLLT11 in the progression of ovarian cancer
por: Tiberio, Paola, et al.
Publicado: (2017)

SOCS2 is dispensable for BCR/ABL1-induced chronic myeloid leukemia-like disease and for normal hematopoietic stem cell function
por: Hansen, N, et al.
Publicado: (2013)

Involvement Value of FLT-3, c-Myc, STAT3, p27, and HOTAIR Gene Expression in Acute Myeloid Leukemia Patients: A Molecular Perspective to a Novel Leukemogenesis Mechanism
por: Shagerdi Esmaeli, Naser, et al.
Publicado: (2023)

The Philadelphia chromosome in leukemogenesis
por: Kang, Zhi-Jie, et al.
Publicado: (2016)

Failure of tofacitinib to achieve an objective response in a DDX3X-MLLT10 T-lymphoblastic leukemia with activating JAK3 mutations
por: Wong, Jonathan, et al.
Publicado: (2020)

Combination of ATO with FLT3 TKIs eliminates FLT3/ITD+ leukemia cells through reduced expression of FLT3
por: Nagai, Kozo, et al.
Publicado: (2018)

OTS167 blocks FLT3 translation and synergizes with FLT3 inhibitors in FLT3 mutant acute myeloid leukemia
por: Eisfelder, Bartholomew J., et al.
Publicado: (2021)

Construction of a new wastewater treatment plant, building 676, route Maxwell
Publicado: (2008)

PT676. Empathic deficits in a mouse model of autism spectrum disorder
por: Sakaguchi, Tetsuya, et al.
Publicado: (2016)

FRI676 Undiagnosed Celiac Disease: A Silent Offender Of Male Osteoporosis
por: Hernandez Castro, Ivonne E, et al.
Publicado: (2023)

Pleiotropic MLLT10 variation confers risk of meningioma and estrogen-mediated cancers
por: Walsh, Kyle M, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_37a8r09rm522dpsr231vnkkmdt